Stock Alert: Corona Remedies, Kotak Mahindra Bank, Aarti Pharmalabs, Equitas Small Finance Bank, Mahindra Lifespace

Corona Remedies has commissioned a European Union Good Manufacturing Practice (EU-GMP)-approved hormone manufacturing facility in Ahmedabad, expanding its hormone manufacturing capacity by 20%.

Kotak Mahindra Bank has signed a business transfer agreement with Deutsche Bank AG (DBAG) to acquire the latter's business undertaking in India.

Aarti Pharmalabs has inaugurated an additional manufacturing block in Maharashtra, adding 3,600 tonnes per annum (TPA) of capacity for Xanthine derivatives production.

Equitas Small Finance Bank's chief financial officer (CFO) and key managerial personnel (KMP), N. Sridharan, has retired upon attaining the age of superannuation.

Mahindra Lifespace Developers has incorporated Mahindra Kandivali Developers (MKDL) as a wholly-owned subsidiary to undertake future real estate development projects.

Avenue Supermarts has opened a new store in Pollachi, Coimbatore, Tamil Nadu, taking its total store count to 503.

Cantabil Retail India has opened five new showrooms across India in June 2026, taking its total showroom count to 667.

Powered by Capital Market - Live News